Company Filing History:
Years Active: 2017-2019
Title: Innovator Xiusheng Wang: Pioneering Advances in Cyclic Peptide Compounds
Introduction
Xiusheng Wang is a distinguished inventor based in Shanghai, China. He holds an impressive portfolio that includes five patents, reflecting his commitment to advancing the field of biopharmaceuticals. His work primarily focuses on cyclic peptide compounds, which have significant implications for various therapeutic applications.
Latest Patents
Xiusheng Wang's latest patents demonstrate his innovative approach to cyclic peptide compounds. One notable patent is for a solvate of a cyclic peptide compound, which includes a method of preparation and its various uses. This invention provides critical insights into the structural formula represented by formula I. Another important patent involves a novel polymorph of a cyclic peptide compound, also represented by formula I, along with its preparation method and potential applications. These inventions highlight his expertise and contributions to the biopharmaceutical field.
Career Highlights
Wang is currently affiliated with Shanghai Techwell Biopharmaceutical Co., Ltd., where he applies his extensive knowledge and skills in developing groundbreaking pharmaceutical solutions. His career has been marked by a sustained focus on research and innovation in peptide chemistry, making him a key figure in the industry.
Collaborations
Throughout his career, Xiusheng Wang has collaborated with notable colleagues, including Shidong Liu and Xiaoming Ji. These partnerships reflect a collaborative spirit that drives innovation and enhances the research development process at Shanghai Techwell Biopharmaceutical.
Conclusion
In conclusion, Xiusheng Wang exemplifies the innovative spirit of modern inventors. With a solid track record of patents and a commitment to advancing pharmaceutical research, he continues to make significant contributions to the field of cyclic peptides. His work not only pushes the boundaries of science but also holds promise for future therapeutic advancements.